Search research articles
Contact Us
Filters
Showing results (341-350 of 368) with videos related to
Page
of 37
Sort By:
Journal of Crohn'S & Colitis
|
December 22, 2010
European evidence-based Consensus on the management of ulcerative colitis: Current management
S P L Travis, E F Stange, M Lémann, et al.
Gastroenterologie Clinique Et Biologique
|
February 15, 2002
[Infliximab therapy for Crohn's disease anoperineal lesions]
A Ouraghi, S Nieuviarts, J L Mougenel, et al.
Gastroenterology
|
March 1, 1996
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives
R Modigliani, J F Colombel, J L Dupas, et al.
Alimentary Pharmacology & Therapeutics
|
August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
M Allez, S Vermeire, N Mozziconacci, et al.
Gut
|
February 24, 2006
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease
W Reinisch, D W Hommes, G Van Assche, et al.
Alimentary Pharmacology & Therapeutics
|
November 22, 2017
Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis
J-F Colombel, W J Sandborn, W Reinisch, et al.
Revista De Gastroenterologia De Mexico
|
March 15, 2015
[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)]
A Dignass, J O Lindsay, A Sturm, et al.
Inflammatory Bowel Diseases
|
August 23, 2001
Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease
W J Sandborn, E V Loftus, J F Colombel, et al.
Mucosal Immunology
|
October 17, 2013
Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice
G Pineton de Chambrun, M Body-Malapel, I Frey-Wagner, et al.
European Journal of Human Genetics : EJHG
|
January 10, 2002
Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease
H Zouali, M Chamaillard, S Lesage, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 368) with videos related to
Sort By:
Page
of 37
Journal of Crohn'S & Colitis
|
December 22, 2010
European evidence-based Consensus on the management of ulcerative colitis: Current management
S P L Travis, E F Stange, M Lémann, et al.
Gastroenterologie Clinique Et Biologique
|
February 15, 2002
[Infliximab therapy for Crohn's disease anoperineal lesions]
A Ouraghi, S Nieuviarts, J L Mougenel, et al.
Gastroenterology
|
March 1, 1996
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives
R Modigliani, J F Colombel, J L Dupas, et al.
Alimentary Pharmacology & Therapeutics
|
August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
M Allez, S Vermeire, N Mozziconacci, et al.
Gut
|
February 24, 2006
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease
W Reinisch, D W Hommes, G Van Assche, et al.
Alimentary Pharmacology & Therapeutics
|
November 22, 2017
Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis
J-F Colombel, W J Sandborn, W Reinisch, et al.
Revista De Gastroenterologia De Mexico
|
March 15, 2015
[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)]
A Dignass, J O Lindsay, A Sturm, et al.
Inflammatory Bowel Diseases
|
August 23, 2001
Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease
W J Sandborn, E V Loftus, J F Colombel, et al.
Mucosal Immunology
|
October 17, 2013
Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice
G Pineton de Chambrun, M Body-Malapel, I Frey-Wagner, et al.
European Journal of Human Genetics : EJHG
|
January 10, 2002
Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease
H Zouali, M Chamaillard, S Lesage, et al.
Page
of 37